Recent studies have investigated the predisposition potential of several germline variants in large cohorts of AML patients [75] or evaluated the clonal evolution and early detection of DDX41-mutant AML by defining the risk associated with DDX41 variants [76]. Here, DDX41 is linked to acute myeloid leukemia.